Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts – implications for clinical biomarker studies

References

• Lisonkova S, Sabr Y, Mayer C, et al. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol. 2014;124(4):771–781.
   PubMed Web of Science ®Google Scholar
• Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299–1306.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Chaemsaithong P, Korzeniewski SJ, et al. Pre-eclampsia part 2: prediction, prevention and management. Nat Rev Nephrol. 2014;10(9):531–540.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Cerdeira AS, Redman C, et al. Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study. Hypertension. 2018;71(2):306–316.
   PubMed Web of Science ®Google Scholar
• Myatt L, Clifton RG, Roberts JM, et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol. 2012;119:1234–1242.
   PubMed Web of Science ®Google Scholar
• Kenny LC, Black MA, Poston L, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study. Hypertension. 2014;64(3):644–652.
   PubMed Web of Science ®Google Scholar
• Andersen LB, Dechend R, Jorgensen JS, et al. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort. Hypertens Pregnancy. 2016;35(3):405–419.
   PubMed Web of Science ®Google Scholar
• Sovio U, Gaccioli F, Cook E, et al. Prediction of preeclampsia using the soluble fms-like tyrosine kinase 1 to placental growth factor ratio: a prospective cohort study of unselected nulliparous women. Hypertension. 2017;69(4):731–738.
   PubMed Web of Science ®Google Scholar
• Yusuf AM, Kahane A, Ray JG. First and second trimester serum sFlt-1/PlGF ratio and subsequent preeclampsia: a systematic review. J Obstet Gynaecol Can. 2017;40:618–628.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao Y, Yu A, et al. Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies. Arch Gynecol Obstet. 2015;292(3):507–518.
   PubMed Web of Science ®Google Scholar
• Myatt L, Roberts JM. Preeclampsia: syndrome or disease? Curr Hypertens Rep. 2015;17(11):83.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Maymon E, et al. The prediction of late-onset preeclampsia: results from a longitudinal proteomics study. PLoS One. 2017;12(7):e0181468.
   PubMed Web of Science ®Google Scholar
• Aghaeepour N, Lehallier B, Baca Q, et al. A proteomic clock of human pregnancy. Am J Obstet Gynecol. 2018;218(3):347.e1–347.e14.
   PubMed Web of Science ®Google Scholar
• Tarca AL, Romero R, Benshalom-Tirosh N, et al. The prediction of early preeclampsia: results from a longitudinal proteomics study. PLoS One. 2019;14(6):e0217273.
   PubMed Web of Science ®Google Scholar
• Ghaemi MS, DiGiulio DB, Contrepois K, et al. Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy. Bioinformatics. 2019;35(1):95–103.
   PubMed Web of Science ®Google Scholar
• Wise PH, Shaw GM, Druzin ML, et al. Risky business: meeting the structural needs of transdisciplinary science. J Pediatr. 2017;191:255–258.
   PubMed Web of Science ®Google Scholar
• ACOG. Methods for estimating the due date – committee opinion number 700. Obstet Gynecol 2017;129(5):e150–e154.
   Google Scholar
• Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–1131.
   PubMed Web of Science ®Google Scholar
• Gold L, Ayers D, Bertino J, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One. 2010;5(12):e15004.
   PubMed Web of Science ®Google Scholar
• Sun BB, Maranville JC, Peters JE, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73–79.
   PubMed Web of Science ®Google Scholar
• Tibshirani R. Regression shrinkage and selection via the LASSO. J R Stat Soc Ser B (Methodological). 1996;58(1):267–288.
   Google Scholar
• Leek JT, Johnson WE, Parker HS, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–883.
   PubMed Web of Science ®Google Scholar
• Hastie T, Tibshirani R. Varying-coefficient models. J R Stat Soc Ser B (Methodological). . 1993;55(4):757–796.
   Google Scholar
• McLean RA, Sanders WL, Stroup WW. A unified approach to mixed linear models. Am Stat. 1991;45:54–64.
   Web of Science ®Google Scholar
• van der Maaten L, Hinton G. Visualizing data using t-SNE. J Mach Learn Res. 2008;9:2579–2605.
   Web of Science ®Google Scholar
• Alexa A, Rahnenfuhrer J. topGO: enrichment analysis for gene ontology. Bioconductor; 2016. http://bioconductor.org/
   Google Scholar
• Rivals I, Personnaz L, Taing L, et al. Enrichment or depletion of a GO category within a class of genes: which test? Bioinformatics. 2007;23(4):401–407.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Catov JM. Preeclampsia more than 1 disease: or is it? Hypertension. 2008;51(4):989–990.
   PubMed Web of Science ®Google Scholar
• Townsend R, Khalil A, Premakumar Y, et al. Prediction of pre-eclampsia: review of reviews. Ultrasound Obstet Gynecol. 2018;54(1):16–27.
   Web of Science ®Google Scholar
• Soreide K, Korner H, Soreide JA. Diagnostic accuracy and receiver-operating characteristics curve analysis in surgical research and decision making. Ann Surg. 2011;253:27–34.
   PubMed Web of Science ®Google Scholar
• Simundic AM. Measures of diagnostic accuracy: basic definitions. EJIFCC. 2009;19:203–211.
   PubMedGoogle Scholar
• Boucoiran I, Thissier-Levy S, Wu Y, et al. Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnancies. Am J Perinatol. 2013;30(7):607–612.
   PubMed Web of Science ®Google Scholar
• Widmer M, Cuesta C, Khan KS, et al. Accuracy of angiogenic biomarkers at ≤20 weeks' gestation in predicting the risk of pre-eclampsia: a WHO multicentre study. Pregnancy Hypertens. 2015;5(4):330–338.
   PubMed Web of Science ®Google Scholar
• Ciobanu A, Wright A, Panaitescu A, et al. Prediction of imminent preeclampsia at 35–37 weeks gestation. Am J Obstet Gynecol. 2019;220(6):584.e1–584.e11.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Korzeniewski SJ, et al. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. J Mater Fetal Neonat Med. 2014;27(2):132–144.
   PubMed Web of Science ®Google Scholar
• Powers RW, Roberts JM, Plymire DA, et al. Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension. 2012;60(1):239–246.
   PubMed Web of Science ®Google Scholar
• Noori M, Donald AE, Angelakopoulou A, et al. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122(5):478–487.
   PubMed Web of Science ®Google Scholar
• Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970–975.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Brown MA, Zeeman GG, et al. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens. 2013;3(1):44–47.
   PubMed Web of Science ®Google Scholar
• Soto E, Romero R, Kusanovic JP, et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Mater Fetal Neonat Med. 2012;25(5):498–507.
   PubMed Web of Science ®Google Scholar
• Weissgerber TL, Roberts JM, Jeyabalan A, et al. Haptoglobin phenotype, angiogenic factors, and preeclampsia risk. Am J Obstet Gynecol. 2012;206(4):358.e10–358.e18.
   PubMed Web of Science ®Google Scholar
• Wolf M, Shah A, Lam C, et al. Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol. 2005;193(1):16–22.
   PubMed Web of Science ®Google Scholar